The startup combines quantum physics, artificial intelligence (AI) and medicinal chemistry in a unique approach to transforming the discovery of therapeutics focused on enzyme inhibition.
Kuano has raised €3.3M across 2 funding rounds from 6 investors, most recently a Seed round in Sep 2023. Based in London, UK; active in Deeptech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-09-12 | Seed | €2.1M | ACF investors,Angel Investors,Ascension Ventures,Meltwind Advisory LLP,Mercia Ventures,o2h Ventures | View deal → |
| 2021-07-08 | Seed | €1.2M | ACF investors,o2h Ventures | View deal → |
